DK139717B - Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof. - Google Patents

Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof.

Info

Publication number
DK139717B
DK139717B DK401270AA DK401270A DK139717B DK 139717 B DK139717 B DK 139717B DK 401270A A DK401270A A DK 401270AA DK 401270 A DK401270 A DK 401270A DK 139717 B DK139717 B DK 139717B
Authority
DK
Denmark
Prior art keywords
aminoalkoxystyroles
beta
aryl
preparation
acid addition
Prior art date
Application number
DK401270AA
Other languages
Danish (da)
Other versions
DK139717C (en
Inventor
Erich Mueller
Roland Maier
Willi Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK139717B publication Critical patent/DK139717B/en
Application granted granted Critical
Publication of DK139717C publication Critical patent/DK139717C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
DK401270AA 1969-08-05 1970-08-04 Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof. DK139717B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (en) 1969-08-05 1969-08-05 β-Aryl-2-aminoalkoxy-styrenes and process for their preparation

Publications (2)

Publication Number Publication Date
DK139717B true DK139717B (en) 1979-04-02
DK139717C DK139717C (en) 1979-09-17

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
DK401270AA DK139717B (en) 1969-08-05 1970-08-04 Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof.

Country Status (25)

Country Link
JP (6) JPS4941433B1 (en)
KR (1) KR780000113B1 (en)
AT (5) AT302344B (en)
BE (1) BE754405A (en)
BG (6) BG18599A3 (en)
CH (6) CH548366A (en)
CS (6) CS170535B2 (en)
DE (1) DE1939809B2 (en)
DK (1) DK139717B (en)
ES (6) ES382429A1 (en)
FI (1) FI54912C (en)
FR (1) FR2068463B1 (en)
GB (1) GB1307436A (en)
HU (1) HU163185B (en)
IE (1) IE34634B1 (en)
IL (1) IL35047A (en)
NL (1) NL7011590A (en)
NO (1) NO135243C (en)
PH (1) PH9520A (en)
PL (2) PL93130B1 (en)
RO (5) RO58861A2 (en)
SE (1) SE382211B (en)
SU (5) SU439965A3 (en)
YU (2) YU198170A (en)
ZA (1) ZA705411B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (en) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (en) * 1978-03-09 1985-10-11 三菱化学株式会社 ω-aminoalkoxystilbenes and their acid addition salts
DE2818765A1 (en) 1978-04-28 1979-11-08 Basf Ag AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE
DE2818999A1 (en) * 1978-04-29 1979-11-15 Basf Ag AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES
DE2818998A1 (en) * 1978-04-29 1979-11-15 Basf Ag 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (en) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL
DE2943405A1 (en) * 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE
DE3006809A1 (en) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
JPS5874379U (en) * 1981-11-16 1983-05-19 富士通株式会社 electronic equipment
NO174506B (en) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogous procedure for the preparation of therapeutically active compounds
SG194985A1 (en) 2011-06-10 2013-12-30 Procter & Gamble Absorbent structure for absorbent articles
CN105816277A (en) 2011-06-10 2016-08-03 宝洁公司 Disposable diapers
EP2717822B1 (en) 2011-06-10 2019-06-05 The Procter and Gamble Company Absorbent core for disposable absorbent articles
EP2740449B1 (en) 2012-12-10 2019-01-23 The Procter & Gamble Company Absorbent article with high absorbent material content
EP3284450B1 (en) 2013-06-14 2020-11-25 The Procter & Gamble Company Absorbent article and absorbent core forming channels when wet
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (en) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbent cores having material free areas
ES2606320T3 (en) 2013-12-19 2017-03-23 The Procter & Gamble Company Absorbent cores that have channel-forming areas and wrapping joints in c

Also Published As

Publication number Publication date
CH548983A (en) 1974-05-15
FR2068463A1 (en) 1971-08-27
JPS4941433B1 (en) 1974-11-08
RO57793A (en) 1975-03-15
ES382430A1 (en) 1972-12-01
ES382426A1 (en) 1972-11-16
CH548367A (en) 1974-04-30
SU450398A3 (en) 1974-11-15
PH9520A (en) 1976-01-09
AT302346B (en) 1972-10-10
JPS5113149B1 (en) 1976-04-26
CH548368A (en) 1974-04-30
KR780000113B1 (en) 1978-04-15
ES382427A1 (en) 1972-11-16
CS170536B2 (en) 1976-08-27
JPS5113146B1 (en) 1976-04-26
AT301565B (en) 1972-09-11
BG17952A3 (en) 1974-03-05
CS170533B2 (en) 1976-08-27
BG18600A3 (en) 1975-02-25
PL78370B1 (en) 1975-06-30
SE382211B (en) 1976-01-19
DE1939809C3 (en) 1979-01-11
FI54912B (en) 1978-12-29
AT303055B (en) 1972-11-10
GB1307436A (en) 1973-02-21
SU439965A3 (en) 1974-08-15
DK139717C (en) 1979-09-17
NL7011590A (en) 1971-02-09
SU428597A3 (en) 1974-05-15
ES382429A1 (en) 1972-11-16
PL93130B1 (en) 1977-05-30
RO57548A (en) 1975-02-15
SU432712A3 (en) 1974-06-15
SU439966A3 (en) 1974-08-15
NO135243B (en) 1976-11-29
IL35047A (en) 1973-05-31
YU37478A (en) 1979-07-10
BE754405A (en) 1971-02-04
CS170534B2 (en) 1976-08-27
CS170538B2 (en) 1976-08-27
CS170537B2 (en) 1976-08-27
BG20095A3 (en) 1975-10-30
CS170535B2 (en) 1976-08-27
AT302344B (en) 1972-10-10
JPS5113148B1 (en) 1976-04-26
RO57794A (en) 1975-06-15
RO58837A (en) 1975-09-15
HU163185B (en) 1973-06-28
IE34634B1 (en) 1975-07-09
RO58861A2 (en) 1975-06-30
IL35047A0 (en) 1970-10-30
NO135243C (en) 1977-03-09
ZA705411B (en) 1971-05-27
YU198170A (en) 1979-07-10
DE1939809B2 (en) 1978-04-13
JPS5113150B1 (en) 1976-04-26
ES382425A1 (en) 1972-11-16
BG18599A3 (en) 1975-02-25
BG17951A3 (en) 1974-03-05
CH548366A (en) 1974-04-30
IE34634L (en) 1971-02-05
CH548982A (en) 1974-05-15
JPS5113147B1 (en) 1976-04-26
ES382428A1 (en) 1972-11-16
FR2068463B1 (en) 1974-08-30
DE1939809A1 (en) 1971-02-18
FI54912C (en) 1979-04-10
AT302345B (en) 1972-10-10
BG17950A3 (en) 1974-03-05
CH548981A (en) 1974-05-15

Similar Documents

Publication Publication Date Title
DK134984B (en) Analogous process for the preparation of alpha-alkylaminopropiophenones or acid addition salts thereof.
DK124884B (en) Analogous process for the preparation of 2-bromo-α-ergocryptine or acid addition salts thereof.
DK129446B (en) Analogous process for the preparation of phenoxyhydroxypropylamines or acid addition salts thereof.
DK127556B (en) Analogous process for the preparation of quinazoline derivatives or acid addition salts thereof.
DK139869B (en) Analogous process for the preparation of phenyl-imidazolyl-alkanoic acid derivatives or salts thereof.
DK139717B (en) Analogous process for the preparation of beta-aryl-2-aminoalkoxystyroles or acid addition salts thereof.
DK131858B (en) Analogous process for the preparation of 4-amino-6-arylpyrimidine compounds or acid addition salts thereof.
DK135278B (en) Analogous process for the preparation of phenoxyisopropanolamine derivatives or acid addition salts thereof.
DK136526B (en) Analogous process for the preparation of substituted naphthylalkylamines or acid addition salts thereof.
DK129577B (en) Analogous process for the preparation of phenacetylguanidines or acid addition salts thereof.
DK127644B (en) Analogous process for the preparation of ergopeptins or acid addition salts thereof.
DK125245B (en) Process for the preparation of γpiperidinobutyrophenone derivatives or acid addition salts thereof.
DK129346B (en) Analogous process for the preparation of imidazole derivatives or acid addition salts thereof.
DK120155B (en) Analogous process for the preparation of aminopropiophenones or acid addition salts thereof.
DK138015B (en) Process for the preparation of substituted N-cycloalkyl-arylamino-imidazolines (2) or acid addition salts thereof.
DK129454B (en) Analogous process for the preparation of ergonorcornine or acid addition salts thereof.
DK125472B (en) Analogous process for the preparation of pyrimidopyridazine derivatives or acid addition salts thereof.
DK127424B (en) Analogous process for the preparation of 4-aryl-1- (4,4-diarylbutyl) -4-hydroxypiperidines or acid addition salts thereof.
DK136151B (en) Analogous process for the preparation of basic substituted tertiary butanols or acid addition salts thereof.
DK129164B (en) Analogous process for the preparation of 3-alkyl-5-aryloxymethylisoxazoles or acid addition salts thereof.
DK131727B (en) Analogous process for the preparation of oxazinobenzoxazines or acid addition salts thereof.
DK127642B (en) Analogous process for the preparation of benzodioxane derivatives or acid addition salts thereof.
DK131147B (en) Process for the preparation of butyrophenone derivatives or acid addition salts thereof.
DK134023B (en) Analogous process for the preparation of acyloxypiperazinyl compounds or acid addition salts thereof.
DK137834B (en) Analogous process for the preparation of triazolobenzodiazepine derivatives or acid addition salts thereof.